0001140361-18-032819.txt : 20180718 0001140361-18-032819.hdr.sgml : 20180718 20180718190210 ACCESSION NUMBER: 0001140361-18-032819 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180718 DATE AS OF CHANGE: 20180718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melo John CENTRAL INDEX KEY: 0001501907 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 18959249 MAIL ADDRESS: STREET 1: C/O AMYRIS, INC. STREET 2: 5885 HOLLIS ST., SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4/A 1 doc1.xml FORM 4/A X0306 4/A 2018-05-01 2018-05-03 0 0001365916 AMYRIS, INC. AMRS 0001501907 Melo John C/O AMYRIS, INC. 5885 HOLLIS ST., SUITE 100 EMERYVILLE CA 94608 1 1 0 0 President and CEO Common Stock 2018-05-01 4 F 0 3265 6.74 D 79907 D Common Stock 2018-05-01 4 F 0 5379 6.74 D 74528 D Due to an unintentional error, 10,776 shares previously sold by the reporting person pursuant to a Rule 10b5-1 trading plan were inadvertently included in a Form 4 filed on May 3, 2018. /s/ John Melo by Stephen Dobson, Attorney-in-Fact 2018-07-18